Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)

1. Ribera, J.-M.
2. García, O.
3. Grande, C.
4. Esteve, J.
5. Oriol, A.
6. Bergua, J.
7. González-Campos, J.
8. Vall-Llovera, F.
9. Tormo, M.
10. Hernández-Rivas, J.-M.
11. García, D.
12. Brunet, S.
13. Alonso, N.
14. Barba, P.
15. Miralles, P.
16. Llorente, A.
17. Montesinos, P.
18. Moreno, M.-J.
19. Hernández-Rivas, J.-A.
20. Bernal, T.